CAR T Pioneer Renier Brentjens Develops Next-Gen Cell Therapies for Solid Tumors
Renier Brentjens, one of the early researchers behind CAR T cell therapy, is now developing a new generation of engineered 'living drug' treatments. His current work aims to extend the success these therapies have had against blood cancers to solid tumors, which have proven far harder to treat with cell-based approaches.